Knee osteoarthritis (OA) is a degenerative joint condition that affects millions of people worldwide, causing pain, stiffness, and loss of mobility. It's a leading cause of disability in people over 50, especially those with a history of joint injury, obesity, or repetitive stress on the knees. As cartilage degrades and inflammation sets in, everyday tasks like walking or climbing stairs become increasingly difficult.

🧬 Direct evidence for hair growth using this exact three-part protocol (MSC + PL + Fibroblast) is limited.

Regenerative medicine is redefining how clinics approach hair restoration. Instead of relying only on mechanical stimulation or transplants, new biologic protocols aim to repair and renew the scalp itself. The most comprehensive approach now combines Wharton’s Jelly mesenchymal stem cells (MSCs), platelet lysate (PL), and autologous fibroblasts.

A surgical neck lift + MSC + fibroblast therapy gives you both mechanical correction and biologic rejuvenation, which are normally opposites.

Here’s how it works and what it delivers in practice:

Abstract

Parkinson’s happens when brain cells that make dopamine wear out. Stem cells can’t fully replace them yet, but some types (especially mesenchymal stem cells, MSCs, from fat or umbilical cord tissue) may calm inflammation and protect remaining neurons. Early human trials show good safety and modest functional gains in some patients.

Human data (very limited)

• Open-label trial (inguinal hernia): Autologous bone-marrow “cell-coated” mesh (described as MSCs) vs. standard Lichtenstein showed fewer early postoperative complaints; small, single-center, open label; methods/reporting quality are limited. surgeryscience.com
• Case report: Complex incisional hernia repaired using a biologic mesh augmented with platelet-rich plasma and bone-marrow MSCs (n=1).

Recent Studies on Wharton's Jelly and Adipose-Derived Stem Cells for COPD

Stem Cell Therapies for COPD: Wharton’s Jelly vs. Adipose-Derived MSCs

Wharton’s Jelly–Derived MSCs in COPD

Wharton’s jelly MSCs (WJ-MSCs) are harvested from umbilical cord tissue, a young and ethically non-contentious source. [1] They express typical MSC markers (CD73, CD90, CD105) and lack hematopoietic ones (CD14, CD34, CD45).

BOTTOM LINE WHICH WORKS BETTER?

Stem cell treatment for COPD (Chronic Obstructive Pulmonary Disease) is an emerging area of regenerative medicine. Here's what you need to know, with a balance of current science, potential, and limitations:

What It Is

Stem cell therapy for COPD typically involves mesenchymal stem cells (MSCs) — usually derived from: